⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5669163 | 1.00 | — | — | |
| SCHEMBL14970377 | 1.00 | — | — | |
| SCHEMBL1861994 | 0.87 | — | — | |
| SCHEMBL422585 | 0.87 | — | — | |
| SCHEMBL14007401 | 0.81 | PLA2G2C (0.40) | — | |
| SCHEMBL1437055 | 0.80 | — | — | |
| SCHEMBL5112339 | 0.80 | — | — | |
| SCHEMBL4578510 | 0.80 | — | — | |
| SCHEMBL5197140 | 0.80 | — | — | |
| SCHEMBL2417291 | 0.79 | TDP1 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1951686-B1 | QUINAZOLINE DERIVATIVES AS A MULTIPLEX INHIBITOR AND METHOD FOR THE PREPARATION THEREOF | HANMI PHARM IND CO LTD (KR) | 2013-04-03 | — | — | EP | claimed |
| US-20080318950-A1 | Quinazoline Derivatives as a Multiplex Inhibitor and Method For the Preparation Thereof | HANMI PHARM. CO., LTD (KR) | 2008-12-25 | — | — | US | claimed |
| CN-101304978-A | Quinazoline derivatives as multiplex inhibitors and process for their preparation | HANMI PHARM IND CO LTD (KR) | 2008-11-12 | — | — | CN | claimed |
| EP-1951686-A1 | QUINAZOLINE DERIVATIVES AS A MULTIPLEX INHIBITOR AND METHOD FOR THE PREPARATION THEREOF | Hanmi Pharm. Co., Ltd. (KR) | 2008-08-06 | — | — | EP | claimed |
| WO-2007055514-A1 | QUINAZOLINE DERIVATIVES AS A MULTIPLEX INHIBITOR AND METHOD FOR THE PREPARATION THEREOF | HANMI PHARM. CO., LTD. (KR) | 2007-05-18 | — | — | WO | claimed |
| EP-4630410-A1 | POLQ INHIBITORS | Astrazeneca AB (SE) | 2025-10-15 | — | — | EP | disclosed |
| CN-120020116-A | Process for the preparation of N-alkenylamides | 中国石油化工股份有限公司 | 2025-05-20 | — | — | CN | disclosed |
| WO-2024121753-A1 | POLQ INHIBITORS | ASTRAZENECA AB (SE) | 2024-06-13 | — | — | WO | disclosed |
| WO-2023072974-A1 | TRICYCLIC HETEROCYCLES | MERCK PATENT GMBH (DE) | 2023-05-04 | — | — | WO | disclosed |
| WO-2021224291-A1 | TRICYCLIC HETEROCYCLES USEFUL AS TEAD BINDERS | MERCK PATENT GMBH (DE) | 2021-11-11 | — | — | WO | disclosed |
| EP-3089971-B1 | COMPOUNDS AND METHODS OF USE | MEDIVATION TECH LLC (US) | 2020-07-29 | — | — | EP | disclosed |
| WO-2020012357-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE | INTEGRAL BIOSCIENCES PVT. LTD. (IN) | 2020-01-16 | — | — | WO | disclosed |
| EP-0239122-B1 | PROCESS FOR THE ENZYMATIC RESOLUTION OF RACEMIC 2-AMINO-1-ALKANOLS | Montedison S.p.A. (IT) | 1992-06-17 | — | — | EP | disclosed |
| EP-0404146-A2 | Enantiomeric enrichment and stereoselective synthesis of chiral amines | CELGENE CORPORATION (US) | 1990-12-27 | — | — | EP | disclosed |
| US-4950606-A | CONTACTING IN AN AQUEOUS MEDIUM IN THE PRESENCE OF AN AMINO ACCEPTOR WITH AN OMEGA-AMINO ACID TRANSAMINASE TO CONVERT ONE OF AMINES TO KETONE | CELGENE CORPORATION (US) | 1990-08-21 | — | — | US | disclosed |
| EP-0239122-A2 | Process for the enzymatic resolution of racemic 2-amino-1-alkanols | Montedison S.p.A. (IT) | 1987-09-30 | — | — | EP | disclosed |
| US-3944618-A | DI-1-AMINO-2-BUTANOL, ETHYLENE DICHLORIDE | AMERICAN CYANAMID COMPANY (US) | 1976-03-16 | — | — | US | disclosed |
| US-3944619-A | ISOLATION FROM L ISOMER USING L(+)-TARTARIC ACID | AMERICAN CYANAMID COMPANY (US) | 1976-03-16 | — | — | US | disclosed |
| US-3944617-A | HYDROLYSIS OF N-(1-(CHLOROMETHYL)-PROPYL)ACETAMIDE | AMERICAN CYANAMID COMPANY (US) | 1976-03-16 | — | — | US | disclosed |
| US-3944608-A | Synthesis of N-[1-(chloromethyl)propyl]acetamide | AMERICAN CYANAMID COMPANY (US) | 1976-03-16 | — | — | US | disclosed |